Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Lung Cancer. 2012 Dec 27;79(3):198–204. doi: 10.1016/j.lungcan.2012.11.019

Table 1.

Patient Age Sex Race Stage Tumor type1 Methylated2
1 82 M Caucasian III AD 38
2 83 M Caucasian II AD 1
3 87 F Caucasian I AD 29
4 87 M Caucasian I AD 47
5 74 M Caucasian I AD 14
63 74 M Caucasian I AD 9
7 55 F Caucasian III AD 29
8 63 M Caucasian II AD 23
9 51 M Caucasian II AD 7
10 73 F Caucasian I AD 13
11 76 M Caucasian I AD 5
12 83 M Caucasian I AD 7
13 79 F Caucasian I AD 25
143 60 F African American I AD 7
15 64 M Caucasian I SCC 19
16 85 F Caucasian I SCC 14
17 69 F Caucasian II SCC 9
18 80 M Caucasian I SCC 5
193 64 M Caucasian III SCC 6
20 66 M Caucasian I SCC 40
21 78 F Caucasian I SCC 16
22 72 M Caucasian I SCC 21
23 78 M Caucasian II SCC 5
24 70 M Caucasian I LC 38
25 74 M Caucasian III LC 5
26 58 M Caucasian III LC 6
1

AD: Adenocarcinoma, SCC: Squamous cell carcinoma, LC: Large cell carcinoma

2

Number of hypermethylated loci identified by RLGS

3

Samples were excluded from QMSP